# Fennec Pharmaceuticals Inc.: filings

FENC · Nasdaq · CIK 1211583 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fenc.md) · [Financials](/companies/fenc/financials.md) · [Filings](/companies/fenc/filings.md) · [Insiders](/companies/fenc/insiders.md)

## Reports and events: 242 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 264, 8-K 123, 144 60, 10-Q 53, 3 21, 10-K 18, DEF 14A 18, SC 13G/A 17, 4/A 12, EFFECT 12, SCHEDULE 13G/A 12, SC 13D/A 11, UPLOAD 11, 424B3 10, CORRESP 9, 424B5 8, SC 13G 7, POS AM 6, S-8 5, 10-Q/A 4, S-1 4, S-3 4, SC 13D 4, 10-K/A 3, D 3, S-8 POS 3, 3/A 2, 8-K/A 2, AW 2, NT 10-Q 2, S-1/A 2, SCHEDULE 13G 2, SC TO-I/A 2, 15-12B 1, 15-12B/A 1, 25 1, 424B7 1, 8-A12B 1, CERTNAS 1, F-3/A 1, FWP 1, RW 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-17 | 20:03 ET | [8-K](/filings/0001104659-26-108565.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-108565 |
| 2026-08-13 | 20:03 ET | [10-Q](/filings/0001104659-26-095884.md) | Quarterly report, period 2026-06-30 | 0001104659-26-095884 |
| 2026-06-10 | 21:19 ET | [8-K](/filings/0001104659-26-072425.md) | 5.07 Shareholder vote results | 0001104659-26-072425 |
| 2026-05-22 | 20:05 ET | [8-K](/filings/0001104659-26-065696.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065696 |
| 2026-05-18 | 21:12 ET | [8-K](/filings/0001104659-26-063271.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-063271 |
| 2026-05-14 | 20:24 ET | [10-Q](/filings/0001104659-26-061213.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061213 |
| 2026-04-28 | 20:46 ET | [8-K](/filings/0001104659-26-050433.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-050433 |
| 2026-04-28 | 20:09 ET | [DEF 14A](/filings/0001104659-26-050339.md) | Proxy statement, period 2026-06-10 | 0001104659-26-050339 |
| 2026-04-22 | 20:05 ET | [8-K](/filings/0001104659-26-046804.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-046804 |
| 2026-04-07 | 20:27 ET | [8-K](/filings/0001104659-26-040414.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040414 |
| 2026-03-27 | 20:44 ET | [10-K](/filings/0001104659-26-036182.md) | Annual report, period 2025-12-31 | 0001104659-26-036182 |
| 2026-03-24 | 20:22 ET | [8-K](/filings/0001104659-26-033885.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-033885 |
| 2026-03-16 | 21:21 ET | [8-K](/filings/0001104659-26-028595.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-028595 |
| 2026-03-04 | 21:23 ET | [8-K](/filings/0001104659-26-023484.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-023484 |
| 2026-02-20 | 21:02 ET | [8-K](/filings/0001104659-26-018128.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-018128 |
| 2025-12-09 | 21:02 ET | [8-K](/filings/0001104659-25-119654.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-119654 |
| 2025-12-02 | 21:02 ET | [8-K](/filings/0001104659-25-117697.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117697 |
| 2025-11-19 | 12:10 ET | [8-K](/filings/0001104659-25-113915.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-113915 |
| 2025-11-18 | 21:05 ET | [8-K](/filings/0001104659-25-113646.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-113646 |
| 2025-11-17 | 11:30 ET | [8-K](/filings/0001104659-25-112912.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112912 |
| 2025-11-13 | 21:02 ET | [10-Q](/filings/0001104659-25-111260.md) | Quarterly report, period 2025-09-30 | 0001104659-25-111260 |
| 2025-08-14 | 20:04 ET | [10-Q](/filings/0001558370-25-011552.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011552 |
| 2025-06-03 | 20:31 ET | [8-K](/filings/0001104659-25-055992.md) | 5.07 Shareholder vote results | 0001104659-25-055992 |
| 2025-05-14 | 20:10 ET | [10-Q](/filings/0001558370-25-007748.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007748 |
| 2025-04-25 | 20:25 ET | [DEF 14A](/filings/0001558370-25-005563.md) | Proxy statement, period 2025-06-03 | 0001558370-25-005563 |
| 2025-03-26 | 20:34 ET | [10-K](/filings/0001558370-25-003710.md) | Annual report, period 2024-12-31 | 0001558370-25-003710 |
| 2025-03-10 | 20:46 ET | [8-K](/filings/0001558370-25-002599.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-002599 |
| 2025-02-07 | 21:52 ET | [8-K](/filings/0001558370-25-000715.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-25-000715 |
| 2024-12-20 | 21:37 ET | [8-K](/filings/0001104659-24-130855.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-130855 |
| 2024-12-20 | 21:36 ET | [8-K](/filings/0001104659-24-130854.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-130854 |
| 2024-11-08 | 21:46 ET | [10-Q](/filings/0001558370-24-015068.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015068 |
| 2024-10-30 | 11:00 ET | [8-K](/filings/0001104659-24-112405.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-112405 |
| 2024-08-13 | 21:10 ET | [10-Q](/filings/0001558370-24-012074.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012074 |
| 2024-08-07 | 22:44 ET | [8-K](/filings/0001104659-24-086369.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-086369 |
| 2024-07-02 | 21:38 ET | [8-K](/filings/0001104659-24-076936.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-076936 |
| 2024-06-25 | 20:11 ET | [8-K](/filings/0001104659-24-074748.md) | 5.07 Shareholder vote results | 0001104659-24-074748 |
| 2024-05-14 | 21:24 ET | [10-Q](/filings/0001558370-24-008162.md) | Quarterly report, period 2024-03-31 | 0001558370-24-008162 |
| 2024-05-13 | 20:42 ET | [DEF 14A](/filings/0001558370-24-007979.md) | Proxy statement, period 2024-06-25 | 0001558370-24-007979 |
| 2024-05-09 | 00:29 ET | [8-K](/filings/0001104659-24-058960.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-058960 |
| 2024-03-29 | 20:14 ET | [10-K](/filings/0001558370-24-004383.md) | Annual report, period 2023-12-31 | 0001558370-24-004383 |
| 2024-03-25 | 20:05 ET | [8-K](/filings/0001104659-24-038444.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-038444 |
| 2024-03-21 | 20:02 ET | [8-K](/filings/0001104659-24-037255.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-037255 |
| 2024-03-06 | 21:07 ET | [8-K/A](/filings/0001104659-24-031470.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-031470 |
| 2024-02-29 | 21:04 ET | [8-K](/filings/0001104659-24-029355.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-029355 |
| 2024-02-02 | 23:42 ET | [8-K](/filings/0001104659-24-009551.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-009551 |
| 2023-12-06 | 01:51 ET | [8-K](/filings/0001104659-23-123728.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-123728 |
| 2023-11-09 | 21:52 ET | [10-Q](/filings/0001558370-23-018614.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018614 |
| 2023-11-07 | 00:38 ET | [8-K](/filings/0001104659-23-114905.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-114905 |
| 2023-08-07 | 21:14 ET | [10-Q](/filings/0001558370-23-013638.md) | Quarterly report, period 2023-06-30 | 0001558370-23-013638 |
| 2023-08-07 | 14:51 ET | [8-K/A](/filings/0001104659-23-088184.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-088184 |

Page 1 of 5. [Older](/companies/fenc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.